Axogen launches resorbable soft tissue allograft for peripheral nerve protection, healing
Key takeaways:
- Axogen announced the full launch of the Avive+ soft tissue matrix.
- The Avive+ soft tissue matrix offers protection and tissue separation to promote healing of the peripheral nerve after traumatic injury.
Axogen Inc. announced the launch of the Avive+ soft tissue matrix for use as a barrier to protect and promote healing of the peripheral nerve after acute traumatic injury, according to a company press release.
The Avive+ soft tissue matrix is a resorbable, multilayer allograft that offers protection and tissue separation to promote healing of the peripheral nerve, according to the release.
“Product innovation is integral to our mission at Axogen,” Karen Zaderej, chair, CEO and president of Axogen, said in the release. “With the introduction of Avive+ soft tissue matrix, we are excited to enhance our comprehensive solutions for nerve protection and address a significant need for patients with compression or non-transected nerve injuries.”
Read more about